Image
|
Figure Caption
Fig. 6 TFLS suppresses the PI3K/AKT/mTOR and MAPK signaling in breast cancer cells. (A, B) Western blot analysis of PI3K, AKT, and mTOR expression and activity in MDA-MB-231 and MDA-MB-468 cells treated with TFLS for 72 h. (C, D) Western blot analysis of JNK, Erk1/2, and p38 expression and activity in MDA-MB-231 and MDA-MB-468 cells treated with TFLS for 72 h. Data are presented as mean ± SD. *p < 0.05, **p < 0.01 compared to the control group
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Pharm Biol